Combatting Burkholderia Cepacia in Neonatal Intensive Care

Burkholderia Cepacia in Neonatal Intensive Care

Abstract

We are writing to bring your attention to a serious issue concerning the emerging threat of Burkholderia cepacia infection in the Neonatal Intensive Care Unit (NICU) and the subsequent challenges in its management. B. cepacia, a risky pathogen for hospital-acquired infections, poses significant health risks to patients due to its high fatality and mortality rates (1). Its emergence as a major pathogen in hospital settings is concerning, particularly in light of its strong intrinsic drug-resistant profile and the emergence of acquired drug resistance patterns (2). While it was initially thought to be linked to contamination from pharmaceutical products like sanitizers and disinfectants, it is now emerging as a deadly pathogen among ICU patients (3).